Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$573M |
| 2 |
Microsoft
MSFT
|
+$529M |
| 3 |
McDonald's
MCD
|
+$469M |
| 4 |
Walt Disney
DIS
|
+$303M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$482M |
| 2 |
Comcast
CMCSA
|
+$481M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$381M |
| 4 |
Sherwin-Williams
SHW
|
+$374M |
| 5 |
CELG
Celgene Corp
CELG
|
+$341M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.22% |
| 2 | Technology | 7.41% |
| 3 | Consumer Discretionary | 6.04% |
| 4 | Financials | 5.89% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
DCH
4251
PUT
Dauch Corp
DCH
$1.38B
| $757K | ﹤0.01% |
40,300
+25,100
| +165% | +$501K |
2013 Q2
15 quarters
|
|
4252
Northern Trust Ultra-Short Fixed Income ETF
RAVI
$1.61B
| $756K | ﹤0.01% |
+10,017
| New | +$756K |
2017 Q1
0 quarters
|
|
|
PTLA
4253
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $756K | ﹤0.01% |
19,300
-9,200
| -32% | -$293K |
2016 Q3
2 quarters
|
|
|
SN
4254
CALL
DELISTED
Sanchez Energy Corporation
SN
| $756K | ﹤0.01% |
79,200
-3,800
| -5% | -$42.5K |
2014 Q2
11 quarters
|
|
4255
Commercial Metals
CMC
$7B
| $755K | ﹤0.01% |
+39,484
| New | +$810K |
2017 Q1
0 quarters
|
|
|
GTY
4256
Getty Realty Corp
GTY
$1.71B
| $755K | ﹤0.01% |
+29,888
| New | +$769K |
2017 Q1
0 quarters
|
|
4257
CALL
NETSCOUT
NTCT
$2.91B
| $755K | ﹤0.01% |
+19,900
| New | +$703K |
2017 Q1
0 quarters
|
|
4258
Invesco Golden Dragon China ETF
PGJ
$83.7M
| $755K | ﹤0.01% |
22,205
-54,636
| -71% | -$1.76M |
2014 Q1
12 quarters
|
|
4259
PUT
Voya Financial
VOYA
$8.77B
| $755K | ﹤0.01% |
19,900
+6,000
| +43% | +$242K |
2013 Q2
15 quarters
|
|
|
PDCO
4260
PUT
DELISTED
Patterson Companies, Inc.
PDCO
| $755K | ﹤0.01% |
16,700
-8,000
| -32% | -$347K |
2013 Q2
15 quarters
|
|
4261
First Trust Emerging Markets AlphaDEX Fund
FEM
$819M
| $753K | ﹤0.01% |
+32,888
| New | +$736K |
2017 Q1
0 quarters
|
|
|
CMD
4262
DELISTED
Cantel Medical Corporation
CMD
| $753K | ﹤0.01% |
9,406
-8,631
| -48% | -$686K |
2015 Q4
5 quarters
|
|
|
GLUU
4263
DELISTED
Glu Mobile Inc.
GLUU
| $753K | ﹤0.01% |
331,511
+88,455
| +36% | +$191K |
2013 Q2
15 quarters
|
|
|
IPHI
4264
PUT
DELISTED
INPHI CORPORATION
IPHI
| $752K | ﹤0.01% |
15,400
+800
| +5% | +$37.4K |
2016 Q3
2 quarters
|
|
4265
CALL
CBRE Group
CBRE
$36.9B
| $751K | ﹤0.01% |
21,600
-1,800
| -8% | -$60.2K |
2013 Q2
15 quarters
|
|
4266
PUT
Avnet
AVT
$8.41B
| $750K | ﹤0.01% |
+16,400
| New | +$759K |
2017 Q1
0 quarters
|
|
|
TWNK
4267
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $749K | ﹤0.01% |
47,224
-610,507
| -93% | -$9.13M |
2016 Q4
1 quarter
|
|
4268
Arrow Financial
AROW
$678M
| $748K | ﹤0.01% |
+27,151
| New | +$788K |
2017 Q1
0 quarters
|
|
4269
Buckle
BKE
$2.25B
| $747K | ﹤0.01% |
+40,154
| New | +$809K |
2017 Q1
0 quarters
|
|
4270
CALL
Nutanix
NTNX
$19.9B
| $747K | ﹤0.01% |
39,800
-20,200
| -34% | -$542K |
2016 Q4
1 quarter
|
|
|
BEAT
4271
CALL
DELISTED
BioTelemetry, Inc.
BEAT
| $747K | ﹤0.01% |
25,800
-1,500
| -5% | -$37.2K |
2016 Q3
2 quarters
|
|
|
EMFM
4272
DELISTED
Global X MSCI Next Emerging & Frontier ETF
EMFM
| $746K | ﹤0.01% |
36,548
-11,051
| -23% | -$220K |
2016 Q4
1 quarter
|
|
|
DNO
4273
CALL
DELISTED
United States Short Oil Fund
DNO
| $746K | ﹤0.01% |
11,100
-700
| -6% | -$45.5K |
2014 Q4
9 quarters
|
|
4274
PUT
Northern Trust
NTRS
$30.8B
| $745K | ﹤0.01% |
8,600
-700
| -8% | -$60.9K |
2013 Q2
15 quarters
|
|
4275
PUT
Zillow
ZG
$6.29B
| $744K | ﹤0.01% |
+22,000
| New | +$784K |
2017 Q1
0 quarters
|
|
Similar funds
Citadel Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $4.43B of net new capital in Q1 2017, opening 1,445 new positions and adding to 2,647 existing holdings. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $482M trimmed.
- Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
- Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
- Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
- Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
- Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
- Citadel Advisors opened 1,445 new positions and closed 1,267 in Q1 2017.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.
Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.